Publications by authors named "Jeffrey A Lieberman"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

27,372

Total Likes

581

Extended Reach

198,109

Social Features

59
M
Muscarinic Cholinergic Receptor Agonist and Peripheral Antagonist for Schizophrenia.
Stephen K Brannan, Sharon Sawchak, Andrew C Miller, Jeffrey A Lieberman, Steven M Paul, Alan Breier

N Engl J Med· February 2021

Videos about Article: user user

2 4 57 2 9 1

View All Article and Social Media Activity
A
A Translational Neuroscience & Computational Evaluation of a D1R Partial Agonist for Schizophrenia (TRANSCENDS): Rationale and Study Design of a Brain-Based Clinical Trial.
Clara Fonteneau, Zailyn Tamayo, Ally Price, Lining Pan, Yvette Afriyie-Agyemang, Jeffrey A Lieberman

medRxiv· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preventing disease progression in schizophrenia: What are we waiting for.
Jeffrey A Lieberman, Alana Mendelsohn, Terry E Goldberg, Robin Emsley

J Psychiatr Res· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of schizophrenia-associated genetic markers in the HLA region as risk factors for tardive dyskinesia.
Ruoyu Wang, Justin Y Lu, Deanna Herbert, Jeffrey A Lieberman, Herbert Y Meltzer

Hum Psychopharmacol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is schizophrenia neurodevelopmental, neurodegenerative or something else: A reply to Murray et al. (2022).
William S Stone, Michael R Phillips, Lawrence H Yang, Lawrence S Kegeles, Jeffrey A Lieberman

Schizophr Res· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polygenic risk scores analyses of psychiatric and metabolic traits with antipsychotic-induced weight gain in schizophrenia: an exploratory study.
Kazunari Yoshida, Victoria S Marshe, Samar S M Elsheikh, Malgorzata Maciukiewicz, Arun K Tiwari, Jeffrey A Lieberman

Pharmacogenomics J· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Illness Phase as a Key Assessment and Intervention Window for Psychosis.
Christian G Kohler, Daniel H Wolf, Anissa Abi-Dargham, Alan Anticevic, Youngsun T Cho, Jeffrey A Lieberman

Biol Psychiatry Glob Open Sci· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased parietal and occipital lobe gyrification predicts conversion to syndromal psychosis in a clinical high-risk cohort.
Rakshathi Basavaraju, Jeanelle France, Hannah C Sigmon, Ragy R Girgis, Gary Brucato, Jeffrey A Lieberman

Schizophr Res· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Analysis of Motivating Factors in 1,725 Worldwide Cases of Mass Murder Between 1900-2019.
Gary Brucato, Hannah Hesson, Gabriella Dishy, Kathryn Lee, Tyler Pia, Jeffrey A Lieberman

J Forens Psychiatry Psychol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Victimology of Mass Shootings and Mass Murders Not Involving Firearms.
Hannah M Hesson, Eileen A Shea, Paul S Appelbaum, Gabriella Dishy, Carol Cohen-Romano, Jeffrey A Lieberman

Violence Vict· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The neurobiology of duration of untreated psychosis: a comprehensive review.
Anthony W Zoghbi, Jeffrey A Lieberman, Ragy R Girgis

Mol Psychiatry· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mass murders involving firearms and other methods in school, college, and university settings: Findings from the Columbia Mass Murder Database.
Ragy R Girgis, Russell Tyler Rogers, Hannah Hesson, Jeffrey A Lieberman, Paul S Appelbaum

J Forensic Sci· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neurodegenerative model of schizophrenia: Growing evidence to support a revisit.
William S Stone, Michael R Phillips, Lawrence H Yang, Lawrence S Kegeles, Ezra S Susser, Jeffrey A Lieberman

Schizophr Res· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How should we diagnose schizophrenia: Don't throw the baby out with the bath water.
Michael B First, Jeffrey A Lieberman

Schizophr Res· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Rapid Rise in Investment in Psychedelics-Cart Before the Horse.
Joshua Phelps, Ravi N Shah, Jeffrey A Lieberman

JAMA Psychiatry· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hippocampal Glutamate and Positive Symptom Severity in Clinical High Risk for Psychosis.
Rakshathi Basavaraju, Jia Guo, Scott A Small, Jeffrey A Lieberman, Ragy R Girgis

JAMA Psychiatry· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-impact rare genetic variants in severe schizophrenia.
Anthony W Zoghbi, Ryan S Dhindsa, Terry E Goldberg, Aydan Mehralizade, Joshua E Motelow, Jeffrey A Lieberman

Proc Natl Acad Sci U S A· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The neurobiology of auditory and visual perceptual abnormalities in a clinical high-risk for psychosis cohort: A pilot morphometric magnetic resonance imaging study.
Ragy R Girgis, Xinyang Feng, Gary Brucato, Hannah C Sigmon, Jeffrey A Lieberman

J Psychiatr Res· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Ventromedial prefrontal cortex/anterior cingulate cortex Glx, glutamate, and GABA levels in medication-free major depressive disorder.
Joshua T Kantrowitz, Zhengchao Dong, Matthew S Milak, Rain Rashid, Lawrence S Kegeles, Jeffrey A Lieberman

Transl Psychiatry· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Trial of New Drug for Schizophrenia. Reply.
Steven M Paul, Alan Breier, Jeffrey A Lieberman, Stephen K Brannan, Sharon Sawchak

N Engl J Med· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Back to the Future - The Therapeutic Potential of Psychedelic Drugs.
Jeffrey A Lieberman

N Engl J Med· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psychotic symptoms in mass shootings . mass murders not involving firearms: findings from the Columbia mass murder database.
Gary Brucato, Paul S Appelbaum, Hannah Hesson, Eileen A Shea, Gabriella Dishy, Jeffrey A Lieberman

Psychol Med· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-viral properties of antipsychotic medications in the time of COVID-19.
Ragy R Girgis, Jeffrey A Lieberman

Psychiatry Res· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis